Carriers of pathogenic MLH1, MSH2, and MSH6 mutations can reduce their risk of developing LS-associated endometrial and ovarian cancers through preventive hysterectomy with salpingo-oophorectomy. Here, MLH1 is linked to ovarian carcinoma.